StockNews.AI
CDLX
StockNews.AI
159 days

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cardlytics

1. Faruqi & Faruqi investigate potential claims against Cardlytics for securities violations. 2. The Company allegedly made misleading statements impacting revenue outlook. 3. Cardlytics stock fell 57.1% after disappointing Q2 2024 results. 4. The firm encourages investors with losses over $50,000 to come forward. 5. A federal class action has been filed with a deadline for lead plaintiffs.

7m saved
Insight
Article

FAQ

Why Very Bearish?

Misleading statements have historically led to significant stock price drops, impacting investor trust. The recent $3.94 drop represents a serious decline in market perception.

How important is it?

The article reveals critical legal challenges that could significantly impact future revenue and stock performance. Investors facing substantial losses are advised to act quickly.

Why Short Term?

Immediate impacts are likely due to current litigation and negative sentiment, affecting trading behavior. Rapid price reactions historically follow legal news.

Related Companies

AMZNFBGOOGL
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Cardlytics To Contact Him Directly To Discuss Their OptionsIf you suffered losses exceeding $50,000 in Cardlytics between March 14, 2024 and August 7, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).[You may also click here for additional information], /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Cardlytics, Inc. ("Cardlytics" or the "Company") (NASDAQ: CDLX) and reminds investors of the March 25, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi Logo (PRNewsfoto/Faruqi & Faruqi, LLP) Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com. As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) increasing consumer engagement led to an increase in consumer incentives; (2) that the Company could not increase its billings commensurate with the increased consumer engagement; (3) that, as a result, there was a significant risk that its revenue growth would slow or decline; (4) that the changes to ADE, which led to increased consumer engagement, led to the "under¬ delivery" of budgets and customers billing estimates; and (5) that, as a result of the foregoing,  Defendants'  positive  statements  about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. On May 8, 2024, after the market closed, the Company revealed that its first quarter 2024 revenue only increased 8% year-over-year, despite a 12% increase in billings, due to a 20.2% increase in consumer incentives.On this news, the Company's stock price fell $5.33, or 36.5%, to close at $9.27 per share on May 9, 2024, on unusually heavy trading volume.On August 7, 2024, after the market closed, Cardlytics released its second quarter 2024 financial results, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution to $36.4 million. The press release also disclosed that Karim Temsamani had stepped down as Chief Executive Officer and from the Board of Directors.On this news, Cardlytics' stock price fell $3.94, or 57.1%, to close at $2.96 per share on August 8, 2024, on unusually heavy trading volume.The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not. Faruqi & Faruqi, LLP also encourages anyone with information regarding Cardlytics' conduct to contact the firm, including whistleblowers, former employees, shareholders and others.To learn more about the Cardlytics class action, go to www.faruqilaw.com/CDLX or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).Follow us for updates on LinkedIn, on X, or on Facebook.Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.SOURCE Faruqi & Faruqi, LLP WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In

Related News